Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lunai Bioworks Inc (LNAI)

Lunai Bioworks Inc (LNAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,810
  • Shares Outstanding, K 24,187
  • Annual Sales, $ 0 K
  • Annual Income, $ -178,010 K
  • EBIT $ -13 M
  • EBITDA $ 157 M
  • 60-Month Beta 0.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.05
  • Most Recent Earnings $-0.08 on 02/17/26
  • Next Earnings Date 05/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 457.36% (+457.36%)
  • Historical Volatility 376.60%
  • IV Percentile 79%
  • IV Rank 40.35%
  • IV High 1,039.55% on 11/06/25
  • IV Low 63.49% on 02/19/26
  • Expected Move (DTE 28) 0.0765 (25.16%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 32
  • Volume Avg (30-Day) 177
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 4,045
  • Open Int (30-Day) 3,428
  • Expected Range 0.2275 to 0.3805

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2621 +15.99%
on 04/15/26
0.9480 -67.93%
on 03/26/26
+0.0921 (+43.46%)
since 03/16/26
3-Month
0.1513 +100.93%
on 03/12/26
1.1150 -72.74%
on 02/10/26
-0.6211 (-67.14%)
since 01/16/26
52-Week
0.1513 +100.93%
on 03/12/26
5.5000 -94.47%
on 05/15/25
-3.2960 (-91.56%)
since 04/16/25

Most Recent Stories

More News
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Collaboration converts patient-led data into trial-ready cohorts to support drug development, commercial partnerships, and revenue-generating opportunities.

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial commercial deployment

LNAI : 0.3040 (-5.85%)
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

SACRAMENTO, Calif. , March 26, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Foundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene Mapping

LNAI : 0.3040 (-5.85%)
Lunai Bioworks: Fiscal Q2 Earnings Snapshot

Lunai Bioworks: Fiscal Q2 Earnings Snapshot

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

SACRAMENTO, Calif. , Feb. 13, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute . Company CEO David Weinstein...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks, Inc. Issues Letter to Shareholders

SACRAMENTO, Calif.   , Feb. 9, 2026 /PRNewswire/ --

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

AI-driven analysis of Phase 2 survival and progression data aims to identify high-benefit patient subgroups and optimize future registrational trial strategy

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Transformer-based biosecurity layer embeds directly into foundation models, using Lunai's proprietary toxicology and in-vivo datasets to detect and prevent creation of previously unknown threat agents...

LNAI : 0.3040 (-5.85%)
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

AI Platform Achieves Key Milestones, Triggering Launch of Alcohol Use Disorder Program

LNAI : 0.3040 (-5.85%)

Business Summary

Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 0.3559
2nd Resistance Point 0.3350
1st Resistance Point 0.3195
Last Price 0.3040
1st Support Level 0.2831
2nd Support Level 0.2622
3rd Support Level 0.2467

See More

52-Week High 5.5000
Fibonacci 61.8% 3.4568
Fibonacci 50% 2.8256
Fibonacci 38.2% 2.1945
Last Price 0.3040
52-Week Low 0.1513

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.